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 2 
Significance and Impact of the study: There is an increased interest in 24 
developing effective microbicidal aerosolised formulations. The development of 25 
a small in-house test chamber allowed the measurement of the microbicidal 26 
efficacy of an aerosolised glycol/ethanol formulation at a low cost. We showed 27 
that a glycol/ethanol aerosolised formulation caused extensive structural 28 
damage in Gram-negative and -positive bacteria resulting in a 3 log10 reduction 29 
in viability.  30 
 31 
Abstract 32 
This study aimed to understand the efficacy and mechanisms of action of an 33 
aerosolised glycol-ethanol formulations against bacteria. We validated a small 34 
scale in-house test chamber to determine the microbicidal efficacy of four 35 
aerosolized formulations combining dipropylene glycol and ethanol against 36 
Staphylococcus aureus and Escherichia coli embedded in alginate. The 37 
aerosolised glycol/ethanol formulation decreased bacterial viability by 3 Log10 38 
and was more efficacious than an ethanol only control formulation. Electron 39 
microscopic examination indicated extensive structural damage in both bacteria, 40 
and membrane damage was confirmed with potassium release in S. aureus 41 
and DNA release in E. coli. The development of a small test chamber facilitated 42 
the measurement of the microbicidal efficacy and experiments to understand 43 
the mechanism of action of an aerosolised microbicidal formulation. 44 
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Introduction 47 
Pathogens discharged into the air may settle on environmental surfaces, which 48 
could then become secondary vehicles for the spread of infectious agents 49 
indoors occurring at the air-surface-air nexus (Gralton et al., 2011; Ijaz et al., 50 
2016). Considering the concern about the potential spread of microorganisms 51 
indoors and the limited techniques for testing new formulations, Sattar and 52 
colleagues (2016) designed a protocol to study survival and inactivation of 53 
human pathogens in indoor air. These authors tested the efficacy of a 54 
microbicidal formulation containing 4% dipropylene glycol (DPG) and 35% 55 
ethanol distributed within a 24.3 m3 aerobiology chamber using an air purifier 56 
with a newly-designed fogger (Sattar et al. unpublished data).  57 
The study of human pathogens aerosols requires the ability to produce them 58 
experimentally in appropriate droplet size and sample them safely for analysis 59 
over a predetermined time periods (Sattar and Ijaz, 1987). Since the recovery 60 
of aerosolised bacterial inocula from large-scale microbicide experiments 61 
presents several technical challenges, the immobilization of bacteria in an 62 
alginate support may provide an appropriate alternative (Shackelford et al., 63 
2006). The alginate matrix provides sufficiently large pores to allow the easy 64 
penetration of microbicide and may enable testing of microbicidal efficacy 65 
without the confounding effects of bacterial aerosol-induced cell injury or drying 66 
(Tattawasart et al., 2000a; Shackelford et al., 2006) or aerosolising bacteria 67 
with the negative effects of aerosolising process on bacterial viability (O’Jeil et 68 
al., 2013). In addition, the use of an alginate matrix allows recovering bacteria 69 
in high number for the study of mechanisms of action (Tattawasart et al., 2000a; 70 
Shackelford et al., 2006). Glycols such as propylene glycol (PG) and triethylene 71 
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glycol (TEG) are greatly used in formulations, generally as solvent, extractant 72 
and on occasions as preservatives at concentrations 15-30% (Rowe et al., 73 
2009). The microbicidal activity of glycols has however not been widely 74 
reported.  75 
The aim of this study was to measure the bactericidal efficacy of several 76 
aerosolised glycol-based formulations and their mechanisms of microbicidal 77 
action using a small scale aerosolisation test chamber. 78 
 79 
Results and discussion 80 
 81 
There is a great interest in gaseous and air decontamination technologies 82 
notably in healthcare settings (Davies et al., 2011). The use of highly reactive 83 
chemistry such as vaporized hydrogen peroxide has been successful in 84 
controlling pathogen outbreaks in healthcare environments (Ray et al., 2010; 85 
Goyal et al., 2014). Aerosolised chlorine-based microbicides have also been 86 
explored against Staphylococcus aureus with various degrees of efficacy 87 
(Thorn et al., 2015). However, these highly reactive chemistries are toxic and 88 
the room to be decontaminated needs to be vacated and sealed during the 89 
gaseous process. In addition, testing the efficacy of aerosolised formulations is 90 
expensive and require the use of specifically designed aerobiology test 91 
chambers (Sattar et al., 2016).  Here, we successfully developed a small scale 92 
test chamber to study the efficacy and mechanisms of action of aerosolised 93 
formulations. The combination of the chamber with an immobilised bacterial 94 
inoculum allowed the recovery of a high bacterial inoculum facilitating the study 95 
of the formulations’ mechanisms of action.  96 
 5 
 97 
Effect of liquid formulations on bacterial growth 98 
We are not aware of any scientific publications describing of the microbicidal 99 
activity of dipropylene glycol. Our results show that the test formulations, 100 
including dipropylene glycol only (6.67%) inhibited the growth of the test 101 
bacteria. All liquid formulations affected bacterial growth in comparison to the 102 
TSB positive growth control (Figures 2 and 3). The formulations containing 103 
glycol, or ethanol or a combination of glycol and ethanol had a more 104 
pronounced effect inhibiting completely the growth of both bacteria comparing 105 
to the blank formulation that affected bacterial growth rate and final OD value 106 
(Figures 2 and 3). 107 
 108 
Bactericidal efficacy of aerosolised formulations 109 
Percentage recoveries of bacteria embedded in the alginate were 90.8% and 110 
91.63% for E. coli and S. aureus, respectively. The use of the fogger 111 
formulations containing glycol in our test chamber (10 sec aerosol exposure, 112 
40-60% RH) produced a reduction in bacterial viability. However, the complete 113 
formulation (Glycol + Ethanol) was significantly (ANOVA; P<0.001) more 114 
efficacious with a reduction of 3.20 ± 0.13 Log10 for S. aureus aureus and 3.19 115 
± 0.39 Log10 cfu ml-1 for E. coli compared to 1.54 ± 0.31 and 1.41 ± 0.15 with 116 
each bacterium respectively (Table 3). There were no statistically significant 117 
differences (ANOVA; P>0.1) between the efficacy of the glycol only, the ethanol 118 
only formulations and the blank formulation (Table 3). The use of chlorine-119 
based aerosols (with 20 min aerosol exposure, 10 min resting time, and 50%RH) 120 
produced 1-5 log10 reduction in S. aureus concentration on stainless steel 121 
 6 
surfaces depending on the initial chlorine solution (sodium hypochlorite, 122 
chlorine dioxide or electrochemically activated solution) (Thorn et al., 2013). 123 
Gaseous chlorine (250 mg l-1) has been used in situ to decontaminate indoor 124 
air pathogens and contributed to a reduction <1500 cfu m3 in bacteria and of 125 
<1000 cfu m3 in fungi (Hsu et al., 2015).  126 
The bactericidal activity of other glycols has been reported. Berry (1944) 127 
reported MIC ethylene glycol monophenyl ether of 0.8% v/v against S. aureus 128 
and 0.5 % v/v against E. coli while a number of chloro-and methyl-substituted 129 
aryl ethers of glycerol, propylene glycol and trimethylene glycol were shown to 130 
have some activity against bacteria, fungi and yeast (Berger et al., 1953). 131 
Propylene glycol has been used as a solvent in combination with phenol with 132 
report of some bactericidal activity (Baker and Twort, 1941). It is however clear 133 
that RH played an important role in the activity of the formulation (Baker and 134 
Twort, 1941). Chirife and colleagues (1983) studied the microbicidal activity of 135 
polyethylene glycol 400 and suggested that the bactericidal activity observed 136 
at 35C was a combination of lowering water activity and a direct effect of 137 
bacterial cells demonstrated by cell clumping. Recently ethylene glycol 138 
bactericidal activity was reported against E. coli with MIC and MBC values of 139 
18 and 24 % v/v (Moghayedi et al. 2017).  140 
 141 
Mechanisms of bactericidal action of aerosolised glycol formulations 142 
The mechanisms of action of the aerosolised formulations were explored. It was 143 
hypothesized that the bactericidal activity observed resulted from membrane 144 
damage. Using the FEI Quanta 200F software (Eindhoven, The Netherlands), 145 
direct SEM examination showed evidence of structural damage for both S. 146 
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aureus and E. coli with all the formulations tested (Figures 4 and 5). Ninety 147 
percent of the bacterial population was damaged following exposure to the 148 
control formulations (Table 3). Such level of inactivation contributes to create a 149 
substantial artefact as demonstrated from the SEM images and OMP analysis.  150 
Loss of bacterial viability during sample preparation prior to testing has been 151 
well reported. The decrease in bacterial concentration depends on the material 152 
used (Best et al., 1988; Thorn et al., 2013) and the type of bacteria; some recent 153 
European efficacy test protocol such as the EN14776 recommends the use of 154 
glycerol with the Gram-negative bacterial inoculum to protect test inocula from 155 
dehydration. Here, the use of the alginate limited bacterial loss and contributed 156 
to the use of a highly reproducible test inoculum concentration, as described by 157 
Shackelford and colleagues (2006). 158 
It is clear that the aerosol of the blank formulation by itself caused membrane 159 
damage, with indication that the Gram-negative was more affected with release 160 
of DNA, although not to the OMP. Although the extent of damage could not be 161 
quantified, the combined formulations seems to disrupt structural integrity of S. 162 
aureus more extensively when compared to the other formulations (Figure 4). 163 
The severity of damage caused by the combined formulation was more 164 
apparent in E. coli (Figure 5).   Exposure to the glycol only or ethanol only 165 
formulation seems to ‘smooth’ the surface of E. coli while the blank formulation 166 
affected the bacterial surface but not to same extent as the combined 167 
formulation (Figure 5). SEM images indicated structural changes when bacteria 168 
were exposed to the formulations with the different formulations.  Damage 169 
caused by the combined glycol and ethanol formulation seemed more severe 170 
in both Gram-negative and Gram-positive bacteria. A recent study showed 171 
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severe bacterial structural damage in E. coli exposed to 25% ethylene glycol 172 
(Moghayedi et al. 2017).  173 
Potassium leakage measurements indicated that the full formulation may 174 
interact with the cytoplasmic membrane of the Gram-positive bacterium, 175 
releasing some potassium, but not larger cell components. Potassium release 176 
is the first indicator of membrane damage followed by larger cytoplasmic 177 
constituents (Maillard, 2002).  Here, a small but statistically significant increase 178 
(ANOVA; P< 0.001) in potassium leakage was observed when testing the glycol 179 
and ethanol (A), and glycol only formulations (B) against S. aureus compared 180 
to the blank formulation (D) (Table 4). No potassium was released from E. coli 181 
exposed to the aerosolised formulations (Table 4). 182 
The release of DNA from bacteria following exposure to the aerosolised 183 
formulations was measured spectrophotometrically following exposure. The 184 
OD260 reading allows for the calculation of the concentration of nucleic acid in 185 
the sample. An OD of 1 corresponds to 50 g ml-1 for DNA. The OD260/OD280 186 
ratio reading provides an estimate of the purity of the nucleic acid. Pure 187 
preparations of DNA have OD260/OD280 values of ≥1.8. There were more DNA 188 
in the E. coli samples than in the S. aureus ones (Table 5). Exposure to the 189 
aerosolised formulation contained glycols and ethanol or to the nebulised blank 190 
formulation resulted in very little DNA release, 4% and 6% of total estimated 191 
DNA in S. aureus and E. coli respectively. 192 
 193 
The results of SDS-PAGE indicated no changes in OMP in E. coli after 194 
exposure to the blank and the formulation containing combined glycols and 195 
ethanol were detected by the technique. There was no apparent change in the 196 
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OMP profile following exposure to the blank or the combined glycol and ethanol 197 
formulation, although an increase in the band concentration of three specific 198 
OMP of 35 kD, 27 kD and 16 kD approximately was observed when bacteria 199 
were exposed to the aerosolised formulations (Figure 6).   200 
In conclusion, the test chamber described in our study allowed the microbicidal 201 
evaluation of foggers containing glycol-based formulations and also 202 
nebulization of blank formulation against bacteria embedded in alginate matrix.  203 
The advantage of the small size chamber is the rapidity of the experiment and 204 
cost to set up (compared to the use of an aerobiology chamber).  One limitation 205 
is that the aerosolised formulations need to be adapted to the small volume of 206 
our test chamber. The bactericidal efficacy of the combined aerosolised glycol 207 
and ethanol formulation could be partly attributed to damaging the cytoplasmic 208 
membrane of Gram-positive bacteria and to damaging the outer membrane of 209 
Gram-negative bacteria. 210 
 211 
Material and methods 212 
 213 
Aerosolized Formulations  214 
Four formulations (Table 1) combining DPG and anhydrous ethanol provided 215 
by Reckitt Benckiser (One Philips Parkway, Montvale, NJ 07645. USA) were 216 
studied. Samples were stored at room temperature prior to fogging. 217 
 218 
Bacterial strains 219 
Staphylococcus aureus (ATCC 6538) and Escherichia coli (ATCC 11229) 220 
commonly used in standard efficacy test protocols were used as test bacteria. 221 
 10 
Both strains were stored on Nutriprotect beads (Fisher Scientific, 222 
Loughborough, UK) at −80 ± 1°C and restricted to a maximum of 2 subcultures 223 
from the original freezer stock prior to any testing. Both strains were grown in 224 
tryptone soya broth (TSB) (Oxoid, Basingstoke, UK) at 37 ± 1°C for 16-24 hours. 225 
Test inoculum were prepared from harvesting an overnight TSB culture 226 
centrifuged at 5,000 g for 10 minutes and re-suspended in phosphate buffer 227 
saline (PBS) (Fisher Scientific, Loughborough, UK). 228 
 229 
Sodium alginate test inoculum preparation 230 
The effects of aerosolised formulations were analysed against vegetative 231 
bacteria embedded in sodium alginate. The test protocol was adapted from the 232 
procedure described in Shackelford et al. (2006). A 1 ml sample of bacterial 233 
suspension was added to a 1 ml cooled 3% (w/v) sodium alginate solution in 234 
deionised water and mixed by pipetting (BDH Chemicals Ltd, Poole, UK). The 235 
final concentration in the bacteria/alginate mixture was 1–10 x 109 cfu ml-1. 236 
Aliquot of alginate/bacteria (0.2 ml) was dispensed onto the centre of a moulds 237 
holder system of M8 flat stainless still washers placed on top of stainless still 238 
coupons grade 2B of 0.22 mm X 0.22 mm (Goodfellows Cambridge Ltd. 239 
Huntington, UK). Both, flat washers and coupons were soaked with 5 % 240 
Decon90 (Decon Laboratories Limited, Hove, UK) in deionised water for 60 min, 241 
rinsed, dried and then autoclaved before use.  242 
Loaded mould holder system was placed into individual wells of sterile 6 well 243 
plates (Corning Costar, Sigma-Aldrich UK) containing 10 ml of 2% calcium 244 
chloride solution (BDH chemicals, Poole, UK) and left for 5 min to form a gel as 245 
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the sodium ions are exchanged with calcium ions and the polymers become 246 
cross-linked (Waldman et al., 1998).  247 
To recover the bacteria from the alginate matrix, both control (no formulation 248 
added) and post formulations exposure, the gels were rinsed in five changes of 249 
10 ml of sterile distilled water and dissolved in 10 ml of McIlvaine’s buffer (0.1 250 
mol l-1 citric acid and 0.2 mol l-1 disodium phosphate at pH 7.4; Fisher Scientific). 251 
Samples were taken from the dissolved gels, serially diluted  in sterile PBS (pH 252 
7.4; Fisher Scientific) and CFU counts were performed using the Miles and 253 
Misra drop count method. The bacterial recovery and microbicidal efficacy (BE) 254 
was calculated as follows: BE= log Nc – log Nb where Nc and Nb represent the 255 
numbers of CFU ml-1 in the control and biocide fogger formulations, respectively. 256 
 257 
In-house test chamber conditions 258 
A small portable aerosolisation test chamber was modified from the test 259 
chamber described by O’Jeil and colleagues (2013). Fogger release conditions 260 
were adapted to the size of the chamber consisted of a 23 cm stainless steel 261 
tube connected at the other end to an Andersen cascade impactor (Westech 262 
Instrument Services Ltd, Henlow, UK). A constant low flow rate measured by a 263 
Copley Scientific DFM2000 (Nottingham, UK) flow meter was generated 264 
through a vacuum pump (Fisherbrand, Loughborough, UK) connected to the 265 
Andersen cascade impactor (Figure 1). Temperature and relative humidity 266 
conditions on surfaces were determined using a S154TH temperature and 267 
relative humidity probe. Testing parameters were established according to the 268 
chamber dimension size. Test operation conditions (Table 2) were set up to 269 
mimic a previous study performed with the aerobiology chamber (Sattar et al., 270 
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2016). The procedure was carried out in a class-2 microbiological safety 271 
cabinet facility. 272 
The blank formulation (Table 1) could not be delivered by fogger due to 273 
excessive foam release. Instead the blank formulation was nebulised using a 274 
nebuliser (Philips Respronics, Best, The Netherlands) connected to the 23 cm 275 
stainless steel tube of the rig. All test parameters were the same for all tested 276 
formulations. 277 
 278 
Bactericidal activity of formulations in suspension  279 
Bacterial growth kinetics was determined using the Bioscreen C Microbial 280 
Analyser (Labsystems, Helsinki, Finland) for both microorganisms using the 281 
four formulations as solutions: glycol+ethanol (A), glycol (B), ethanol (C) and 282 
blank (D). Controls consisted of each bacterium growing in TSB. The Bioscreen 283 
was run for 24 h at 25°C and readings were taken using a wideband filter (420-284 
580nm) every 15 min preceded by 10 s shaking. 285 
 286 
Microbicide mechanisms of action 287 
Bacterial gross structural damage following exposure to aerosolised 288 
formulations was explored by scanning electron microscopic examination 289 
(SEM imaging) (Walkera et al., 2003) using the FEI Quanta 200F (Eindhoven, 290 
The Netherlands). Loss of (cytoplasmic) membrane integrity was measured 291 
with potassium leakage according to Walsh et al. (2003). A number of controls 292 
were performed including boiled bacteria at 80ºC for 20 min (maximum 293 
potassium release; positive control 1), boiled bacteria embedded in the matrix 294 
at 80ºC for 20 min (effect of alginate on potassium release; positive control 2), 295 
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effect of nebulisation on the release of K+ from embedded bacteria in the 296 
alginate (nebulisation control). Potassium release was measured by inductively 297 
coupled plasma mass spectrometry (Agilent 7900 ICP-MS). A five-point 298 
calibration (1, 0.1, 0.01 and 0.001 mg l-1, (Tune) and calibration blank (CAL)) 299 
was run and an internal standard (IS) was used throughout the analysis.  All 300 
standards (Tune/Calibration and IS) are certified reference standards from 301 
Agilent. Samples were run in duplicate with blanks in between different samples 302 
to ensure there was no carryover of K+. 303 
To evidence gross membrane damage, DNA release was measured by UV 304 
spectrometry following exposure to the four formulations. Following exposure 305 
to aerosolised formulation and dissolution of the alginate, samples were added 306 
to a 1 cm path-length cuvette and OD recorded 260 nm and at 280 nm. Samples 307 
with an OD of 1 at 260 nm contain approximately 50 µg ml−1 double-stranded 308 
DNA (Nicklas and Buel, 2003).  309 
Positive controls consisted in DNA measured spectrophotometrically of boiled 310 
bacteria at 80ºC during 20 min. 311 
Damage to the Gram-negative outer membrane proteins (OMP) after exposure 312 
to the different formulations were examined using SDS-PAGE according to 313 
Tattawasart and colleagues (2000b) with the silver staining performed 314 
according to Hitchcock and Brown (1983). ImageJ software (Schindelin et al., 315 
2012) was used as a semi-quantitative tool to determine the amount of OMP 316 
observed.  317 
 318 
Statistical analysis  319 
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All experiments were performed in triplicate unless otherwise stated. Bacterial 320 
reduction and effects of the possible mechanism of action of the formulations 321 
tested were compared by one-way ANOVA and Tukey tests with a 95% 322 
confidence level using Rstudio software (Version 1.1.383).  Results were 323 
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Table 1 Aerosolized formulations tested 421 
Sample Active Alcohol Concentration (%) 
Full formulation (A) Dipropylene 
glycol 
Anhydrous ethanol  6.67% / 46.67% 
Glycol formulation (B) Dipropylene 
glycol 
- 6.67% 
Ethanol formulation (C) - Anhydrous ethanol  46.67% 
Blank formulation (D) - - 0 
 422 
Table 2  In-house chamber testing conditions  423 
Parameter Specification Condition tested 
Chamber dimension Size 230 cm3  
Test operation Air rate (flow) 2 l min-1 
 Soil load - 
 Fogger release 10 sec 
 Relative humidity 40-60% 
 Temperature 24C 
Glycol release Concentration 0.18 g 
Microorganisms tested Bacterial concentration 1 x 109 CFU ml-1 
 424 
 20 
Table 3 Bactericidal efficacy of aerosolised formulations against S. aureus and E. coli with a flow of 2.0 l min-1. 425 






 Recovery Reduction Recovery Reduction 
Complete formulation-
Glycol and Ethanol 
9.93 ± 0.15 6.73 ± 0.04 3.20 ± 0.13 9.93 ± 0.05 6.74 ± 0.33 3.19 ± 0.39 
Glycol only formulation 9.68 ± 0.00 8.12 ± 0.20 1.56 ± 0.20 9.68 ± 0.11 7.81 ± 0.18 1.87 ± 0.26 
Ethanol only formulation 9.68 ± 0.00 7.90 ± 0.20 1.78 ± 0.20 9.68 ± 0.11 7.61 ±0 .44 2.07 ± 0.52 
Blank formulation 9.38 ± 0.00 7.84 ± 0.31 1.54 ± 0.31 9.07 ± 0.00 7.66 ± 0.15 1.41 ± 0.15 
426 
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Table 4  Potassium release from S. aureus and E. coli after exposure with 427 
aerosolised or nebulised formulations.  428 
 429 
 430 
  431 
Potassium Release  (ppm) 
SAMPLE (n=2) S. aureus E. coli 
Positive control: bacteria only 100.99 26.75 
Positive control: bacteria + matrix 48.51 12.36 
Nebulisation control 0.57 0.14 
Blank formulation 0.69 0.19 
Complete formulation-Glycol and Ethanol 0.91 0.26 
Glycol only formulation 0.87 0.19 
Ethanol only formulation 0.49 0.18 
 22 
Table 5  DNA release from S. aureus and E. coli following exposure to the aerosolised formulations.  432 
SAMPLE (n=2) OD260 OD280 
OD260:O
D280 
Estimated DNA concentration  
(g ml-1) 
S. aureus 
Positive control (boiled bacteria) 0.50 0.20 2.5 25.0 
Complete formulation-Glycol and Ethanol 0.02 0.02 1.00 1.0 
Blank formulation 0.02 0.01 1.67 1.0 
E. coli 
Positive control (boiled bacteria) 3.00 2.02 1.49 150 
Complete formulation-Glycol and Ethanol 0.19 0.09 2.01 9.5 













Figure 2 Effect of the tested formulations on the growth of S. aureus. (◼) 443 
Complete formulation-Glycol and Ethanol; (◼): Glycol only formulation; (◼) 444 




  449 
Vacuum 
pump 








Figure 3 Effect of the tested formulations on the growth of E. coli. (◼) Complete 450 
formulation-Glycol and Ethanol; (◼): Glycol only formulation; (◼) Ethanol only 451 
formulation; (◼): Blank formulation and (◼): growth control (TSB). (n=32) 452 
 453 
 454 
  455 
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Figure 4 SEM images of S. aureus after exposure to aerosolised 456 
formulations. (A) Complete formulation-Glycol and Ethanol; (B): Glycol only 457 
formulation; (C) Ethanol only formulation; (D): Blank formulation. Bacteria 458 
were coloured using the GNU Image Manipulation Program (GIMP) version 459 
2.8.22. 460 
 461 
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 478 
Figure 5 SEM images of E. coli after exposure to aerosolised formulations. 479 
(A) Complete formulation-Glycol and Ethanol; (B): Glycol only formulation; (C) 480 
Ethanol only formulation; (D): Blank formulation. Bacteria were coloured using 481 
the GNU Image Manipulation Program (GIMP) version 2.8.22. 482 
 483 
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Figure 6 SDS-PAGE analysis of outer membrane proteins. Line 1: Standard 499 
molecular weight; line 2: control E. coli without aerosolized 500 
formulation; line 3. E. coli treated with the blank formulation (D) and 501 
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